HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Amelioration of experimental parkinsonism by intrahypothalamic administration of haloperidol.

Abstract
Accumulation of amines in the degenerating axons of ascending catecholamine-containing neurons in the hypothalamus has been proposed as a site of function neurotransmitter release and may thereby participate in the development of motor impairment seen after central dopamine-depleting lesions. To test this hypothesis further the dopamine receptor antagonist haloperidol (1 microL of a 14 nmol solution) was injected directly into the lateral hypothalamus (LH) in 6 different injection regimes to determine whether amphetamine-induced turning could be attenuated with this treatment. The injection of haloperidol at 1 and 24 h (group 1), 24 h (group 2) or 6+ 7 d (group 3) after 6-hydroxydopamine (6-OHDA) did not modify amphetamine-induced turning. However, the injection of haloperidol at 1 h, 24 h, 7 d, and 8 d (group 4), days 1-7 (group 5), or gradual infusion (14 nmol/microliters/h) for 7 days (group 6) all reduced the 6-OHDA-induced turning to a level similar to that of controls. These results add further support to the contention that amines are released from the axons of degenerating neurones in the hypothalamus and that this phenomenon participates in the elicitation of behavioral impairment attributed solely to the loss of functional neurotransmitters from terminal fields. Furthermore, the data emphasize the importance of hypothalamic pathology in the development of Parkinsonism and suggest that intrahypothalamic administration of dopamine blocking agents might be useful in the treatment of Parkinsonism.
AuthorsG L Willis, G C Smith, G M Pavey, R Sandyk
JournalThe International journal of neuroscience (Int J Neurosci) 1992 Jul-Aug Vol. 65 Issue 1-4 Pg. 187-97 ISSN: 0020-7454 [Print] England
PMID1341681 (Publication Type: Journal Article)
Chemical References
  • Oxidopamine
  • Amphetamine
  • Haloperidol
Topics
  • Amphetamine (pharmacology)
  • Animals
  • Brain Mapping
  • Dominance, Cerebral (drug effects, physiology)
  • Functional Laterality (drug effects)
  • Haloperidol (pharmacology)
  • Hypothalamic Area, Lateral (drug effects)
  • Hypothalamus (drug effects, physiopathology)
  • Injections
  • Male
  • Microscopy, Fluorescence
  • Motor Activity (drug effects, physiology)
  • Oxidopamine (pharmacology)
  • Parkinson Disease, Secondary (physiopathology)
  • Rats
  • Rats, Sprague-Dawley
  • Stereotyped Behavior (drug effects, physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: